JACOB MANDEL to Angiogenesis Inhibitors
This is a "connection" page, showing publications JACOB MANDEL has written about Angiogenesis Inhibitors.
Connection Strength
0.595
-
Update on anti-angiogenic treatment for malignant gliomas. Curr Oncol Rep. 2014 Apr; 16(4):380.
Score: 0.390
-
Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol. 2015 Sep; 124(3):501-6.
Score: 0.107
-
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
Score: 0.098